nodes	percent_of_prediction	percent_of_DWPC	metapath
Imiquimod—CYP1A2—Estropipate—osteoporosis	0.107	0.209	CbGbCtD
Imiquimod—CYP3A4—Estropipate—osteoporosis	0.0562	0.11	CbGbCtD
Imiquimod—CYP3A4—Calcitriol—osteoporosis	0.0562	0.11	CbGbCtD
Imiquimod—CYP1A2—Conjugated Estrogens—osteoporosis	0.0507	0.099	CbGbCtD
Imiquimod—CYP3A4—Ergocalciferol—osteoporosis	0.0449	0.0877	CbGbCtD
Imiquimod—CYP1A2—Estradiol—osteoporosis	0.0445	0.0869	CbGbCtD
Imiquimod—CYP3A4—Raloxifene—osteoporosis	0.0375	0.0732	CbGbCtD
Imiquimod—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0362	0.0707	CbGbCtD
Imiquimod—CYP3A4—Cholecalciferol—osteoporosis	0.0289	0.0565	CbGbCtD
Imiquimod—CYP3A4—Conjugated Estrogens—osteoporosis	0.0266	0.0519	CbGbCtD
Imiquimod—CYP3A4—Estradiol—osteoporosis	0.0233	0.0455	CbGbCtD
Imiquimod—TLR8—Trafficking and processing of endosomal TLR—CTSK—osteoporosis	0.0167	0.144	CbGpPWpGaD
Imiquimod—TLR7—Trafficking and processing of endosomal TLR—CTSK—osteoporosis	0.0127	0.109	CbGpPWpGaD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—IRAK3—osteoporosis	0.00332	0.0286	CbGpPWpGaD
Imiquimod—TLR8—Toll-Like Receptors Cascades—IRAK3—osteoporosis	0.00328	0.0283	CbGpPWpGaD
Imiquimod—CYP3A4—Drug Induction of Bile Acid Pathway—SLC51A—osteoporosis	0.00284	0.0245	CbGpPWpGaD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—IRAK3—osteoporosis	0.00251	0.0217	CbGpPWpGaD
Imiquimod—TLR7—Toll-Like Receptors Cascades—IRAK3—osteoporosis	0.00249	0.0214	CbGpPWpGaD
Imiquimod—TLR8—Toll-Like Receptors Cascades—CTSK—osteoporosis	0.00249	0.0214	CbGpPWpGaD
Imiquimod—TLR8—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—AGER—osteoporosis	0.00197	0.017	CbGpPWpGaD
Imiquimod—TLR8—MyD88 dependent cascade initiated on endosome—AGER—osteoporosis	0.00194	0.0167	CbGpPWpGaD
Imiquimod—TLR7—Toll-Like Receptors Cascades—CTSK—osteoporosis	0.00188	0.0162	CbGpPWpGaD
Imiquimod—TLR8—Toll Like Receptor 9 (TLR9) Cascade—AGER—osteoporosis	0.00187	0.0161	CbGpPWpGaD
Imiquimod—TLR8—Toll-like Receptor Signaling Pathway—SPP1—osteoporosis	0.00166	0.0143	CbGpPWpGaD
Imiquimod—TLR7—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—AGER—osteoporosis	0.00149	0.0129	CbGpPWpGaD
Imiquimod—TLR7—MyD88 dependent cascade initiated on endosome—AGER—osteoporosis	0.00147	0.0127	CbGpPWpGaD
Imiquimod—TLR7—Toll Like Receptor 9 (TLR9) Cascade—AGER—osteoporosis	0.00142	0.0122	CbGpPWpGaD
Imiquimod—TLR8—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6R—osteoporosis	0.00141	0.0122	CbGpPWpGaD
Imiquimod—TLR8—MyD88 dependent cascade initiated on endosome—IL6R—osteoporosis	0.00138	0.0119	CbGpPWpGaD
Imiquimod—TLR8—Toll Like Receptor 9 (TLR9) Cascade—IL6R—osteoporosis	0.00134	0.0115	CbGpPWpGaD
Imiquimod—TLR8—Toll-Like Receptors Cascades—AGER—osteoporosis	0.00133	0.0114	CbGpPWpGaD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—SPP1—osteoporosis	0.0013	0.0112	CbGpPWpGaD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—SPP1—osteoporosis	0.00126	0.0108	CbGpPWpGaD
Imiquimod—TLR7—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6R—osteoporosis	0.00107	0.00921	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—IRAK3—osteoporosis	0.00106	0.00916	CbGpPWpGaD
Imiquimod—TLR7—MyD88 dependent cascade initiated on endosome—IL6R—osteoporosis	0.00105	0.00905	CbGpPWpGaD
Imiquimod—TLR7—Toll Like Receptor 9 (TLR9) Cascade—IL6R—osteoporosis	0.00101	0.00873	CbGpPWpGaD
Imiquimod—TLR7—Toll-Like Receptors Cascades—AGER—osteoporosis	0.00101	0.00868	CbGpPWpGaD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—SPP1—osteoporosis	0.000981	0.00846	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—ACTG1—osteoporosis	0.000972	0.00838	CbGpPWpGaD
Imiquimod—TLR8—Toll-Like Receptors Cascades—IL6R—osteoporosis	0.00095	0.00819	CbGpPWpGaD
Imiquimod—TLR8—Toll-like Receptor Signaling Pathway—IL1B—osteoporosis	0.000936	0.00807	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—IRAK3—osteoporosis	0.000805	0.00694	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—CTSK—osteoporosis	0.000805	0.00694	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—NFATC1—osteoporosis	0.000792	0.00683	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—ACTG1—osteoporosis	0.000736	0.00635	CbGpPWpGaD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—IL1B—osteoporosis	0.000731	0.0063	CbGpPWpGaD
Imiquimod—TLR7—Toll-Like Receptors Cascades—IL6R—osteoporosis	0.00072	0.0062	CbGpPWpGaD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—IL1B—osteoporosis	0.000709	0.00612	CbGpPWpGaD
Imiquimod—TLR8—Toll-like Receptor Signaling Pathway—TNF—osteoporosis	0.000679	0.00585	CbGpPWpGaD
Imiquimod—TLR8—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—osteoporosis	0.000628	0.00542	CbGpPWpGaD
Imiquimod—TLR8—Immune System—IRAK3—osteoporosis	0.000619	0.00533	CbGpPWpGaD
Imiquimod—TLR8—MyD88 dependent cascade initiated on endosome—IL6—osteoporosis	0.000617	0.00532	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—CTSK—osteoporosis	0.00061	0.00526	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—NFATC1—osteoporosis	0.0006	0.00517	CbGpPWpGaD
Imiquimod—TLR8—Toll Like Receptor 9 (TLR9) Cascade—IL6—osteoporosis	0.000595	0.00513	CbGpPWpGaD
Imiquimod—TLR8—Immune System—ACTG1—osteoporosis	0.000566	0.00488	CbGpPWpGaD
Imiquimod—CYP1A2—Estrogen Receptor Pathway—ESR1—osteoporosis	0.000556	0.00479	CbGpPWpGaD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—IL1B—osteoporosis	0.000554	0.00477	CbGpPWpGaD
Imiquimod—TLR8—Toll-like Receptor Signaling Pathway—IL6—osteoporosis	0.000548	0.00472	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—KL—osteoporosis	0.000547	0.00472	CbGpPWpGaD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—TNF—osteoporosis	0.00053	0.00457	CbGpPWpGaD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—TNF—osteoporosis	0.000515	0.00444	CbGpPWpGaD
Imiquimod—TLR7—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—osteoporosis	0.000476	0.0041	CbGpPWpGaD
Imiquimod—TLR8—Immune System—RAP1A—osteoporosis	0.000473	0.00408	CbGpPWpGaD
Imiquimod—TLR7—Immune System—IRAK3—osteoporosis	0.000469	0.00404	CbGpPWpGaD
Imiquimod—TLR8—Immune System—CTSK—osteoporosis	0.000469	0.00404	CbGpPWpGaD
Imiquimod—TLR7—MyD88 dependent cascade initiated on endosome—IL6—osteoporosis	0.000467	0.00403	CbGpPWpGaD
Imiquimod—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.000466	0.00402	CbGpPWpGaD
Imiquimod—TLR8—Immune System—NFATC1—osteoporosis	0.000461	0.00398	CbGpPWpGaD
Imiquimod—CYP1A2—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.00046	0.00397	CbGpPWpGaD
Imiquimod—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—osteoporosis	0.000453	0.00391	CbGpPWpGaD
Imiquimod—TLR7—Toll Like Receptor 9 (TLR9) Cascade—IL6—osteoporosis	0.000451	0.00389	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—AGER—osteoporosis	0.00043	0.00371	CbGpPWpGaD
Imiquimod—TLR7—Immune System—ACTG1—osteoporosis	0.000429	0.0037	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—ADCY5—osteoporosis	0.000429	0.0037	CbGpPWpGaD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—IL6—osteoporosis	0.000428	0.00369	CbGpPWpGaD
Imiquimod—TLR8—Toll-Like Receptors Cascades—IL6—osteoporosis	0.000423	0.00365	CbGpPWpGaD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—IL6—osteoporosis	0.000415	0.00358	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—KL—osteoporosis	0.000415	0.00358	CbGpPWpGaD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—TNF—osteoporosis	0.000402	0.00346	CbGpPWpGaD
Imiquimod—CYP1A2—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.000378	0.00326	CbGpPWpGaD
Imiquimod—TLR8—Immune System—PSMA5—osteoporosis	0.000377	0.00325	CbGpPWpGaD
Imiquimod—TLR8—Immune System—PSMA2—osteoporosis	0.000377	0.00325	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—IRS2—osteoporosis	0.000375	0.00323	CbGpPWpGaD
Imiquimod—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.00036	0.0031	CbGpPWpGaD
Imiquimod—TLR7—Immune System—RAP1A—osteoporosis	0.000358	0.00309	CbGpPWpGaD
Imiquimod—TLR7—Immune System—CTSK—osteoporosis	0.000355	0.00306	CbGpPWpGaD
Imiquimod—CYP3A4—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.000355	0.00306	CbGpPWpGaD
Imiquimod—TLR7—Immune System—NFATC1—osteoporosis	0.00035	0.00301	CbGpPWpGaD
Imiquimod—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—osteoporosis	0.000339	0.00292	CbGpPWpGaD
Imiquimod—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	0.000337	0.00291	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—IRS1—osteoporosis	0.000327	0.00282	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—AGER—osteoporosis	0.000326	0.00281	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—ADCY5—osteoporosis	0.000325	0.0028	CbGpPWpGaD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—IL6—osteoporosis	0.000324	0.0028	CbGpPWpGaD
Imiquimod—TLR7—Toll-Like Receptors Cascades—IL6—osteoporosis	0.000321	0.00276	CbGpPWpGaD
Imiquimod—TLR8—Immune System—KL—osteoporosis	0.000319	0.00275	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—IL6R—osteoporosis	0.000308	0.00265	CbGpPWpGaD
Imiquimod—CYP1A2—Tryptophan metabolism—CYP19A1—osteoporosis	0.000303	0.00261	CbGpPWpGaD
Imiquimod—CYP3A4—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.000292	0.00252	CbGpPWpGaD
Imiquimod—TLR7—Immune System—PSMA2—osteoporosis	0.000285	0.00246	CbGpPWpGaD
Imiquimod—TLR7—Immune System—PSMA5—osteoporosis	0.000285	0.00246	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—IRS2—osteoporosis	0.000284	0.00245	CbGpPWpGaD
Imiquimod—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	0.00026	0.00224	CbGpPWpGaD
Imiquimod—TLR8—Immune System—AGER—osteoporosis	0.000251	0.00216	CbGpPWpGaD
Imiquimod—TLR8—Immune System—ADCY5—osteoporosis	0.00025	0.00215	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—IRS1—osteoporosis	0.000248	0.00214	CbGpPWpGaD
Imiquimod—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.000245	0.00211	CbGpPWpGaD
Imiquimod—CYP1A2—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.000242	0.00208	CbGpPWpGaD
Imiquimod—TLR7—Immune System—KL—osteoporosis	0.000242	0.00208	CbGpPWpGaD
Imiquimod—CYP3A4—Tryptophan metabolism—CYP19A1—osteoporosis	0.000234	0.00202	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—IL6R—osteoporosis	0.000233	0.00201	CbGpPWpGaD
Imiquimod—CYP1A2—Arachidonic acid metabolism—GPX1—osteoporosis	0.000231	0.00199	CbGpPWpGaD
Imiquimod—Visual impairment—Estradiol—osteoporosis	0.000219	0.000588	CcSEcCtD
Imiquimod—TLR8—Immune System—IRS2—osteoporosis	0.000218	0.00188	CbGpPWpGaD
Imiquimod—Anorexia—Pamidronate—osteoporosis	0.000218	0.000587	CcSEcCtD
Imiquimod—Chest pain—Zoledronate—osteoporosis	0.000218	0.000587	CcSEcCtD
Imiquimod—Arthralgia—Zoledronate—osteoporosis	0.000218	0.000587	CcSEcCtD
Imiquimod—Myalgia—Zoledronate—osteoporosis	0.000218	0.000587	CcSEcCtD
Imiquimod—Palpitations—Conjugated Estrogens—osteoporosis	0.000218	0.000587	CcSEcCtD
Imiquimod—Insomnia—Risedronate—osteoporosis	0.000218	0.000586	CcSEcCtD
Imiquimod—Anxiety—Zoledronate—osteoporosis	0.000217	0.000585	CcSEcCtD
Imiquimod—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000217	0.000584	CcSEcCtD
Imiquimod—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000217	0.000583	CcSEcCtD
Imiquimod—Paraesthesia—Risedronate—osteoporosis	0.000216	0.000582	CcSEcCtD
Imiquimod—Pruritus—Estropipate—osteoporosis	0.000216	0.00058	CcSEcCtD
Imiquimod—Discomfort—Zoledronate—osteoporosis	0.000216	0.00058	CcSEcCtD
Imiquimod—Asthenia—Alendronate—osteoporosis	0.000215	0.00058	CcSEcCtD
Imiquimod—Hypersensitivity—Ibandronate—osteoporosis	0.000215	0.000579	CcSEcCtD
Imiquimod—Cough—Conjugated Estrogens—osteoporosis	0.000215	0.000579	CcSEcCtD
Imiquimod—Dyspnoea—Risedronate—osteoporosis	0.000215	0.000578	CcSEcCtD
Imiquimod—Erythema multiforme—Estradiol—osteoporosis	0.000215	0.000577	CcSEcCtD
Imiquimod—Convulsion—Conjugated Estrogens—osteoporosis	0.000214	0.000575	CcSEcCtD
Imiquimod—Dry mouth—Zoledronate—osteoporosis	0.000213	0.000574	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000213	0.000574	CcSEcCtD
Imiquimod—Fatigue—Ethinyl Estradiol—osteoporosis	0.000213	0.000573	CcSEcCtD
Imiquimod—Pruritus—Alendronate—osteoporosis	0.000212	0.000571	CcSEcCtD
Imiquimod—Dyspepsia—Risedronate—osteoporosis	0.000212	0.000571	CcSEcCtD
Imiquimod—Eye disorder—Estradiol—osteoporosis	0.000212	0.00057	CcSEcCtD
Imiquimod—Tinnitus—Estradiol—osteoporosis	0.000212	0.000569	CcSEcCtD
Imiquimod—Hypersensitivity—Calcitriol—osteoporosis	0.000211	0.000567	CcSEcCtD
Imiquimod—Flushing—Estradiol—osteoporosis	0.000211	0.000567	CcSEcCtD
Imiquimod—Arthralgia—Conjugated Estrogens—osteoporosis	0.00021	0.000565	CcSEcCtD
Imiquimod—Chest pain—Conjugated Estrogens—osteoporosis	0.00021	0.000565	CcSEcCtD
Imiquimod—Myalgia—Conjugated Estrogens—osteoporosis	0.00021	0.000565	CcSEcCtD
Imiquimod—Asthenia—Ibandronate—osteoporosis	0.00021	0.000564	CcSEcCtD
Imiquimod—Anxiety—Conjugated Estrogens—osteoporosis	0.000209	0.000563	CcSEcCtD
Imiquimod—Nausea—Etidronic acid—osteoporosis	0.000209	0.000563	CcSEcCtD
Imiquimod—Oedema—Zoledronate—osteoporosis	0.000209	0.000563	CcSEcCtD
Imiquimod—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000209	0.000561	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000209	0.000561	CcSEcCtD
Imiquimod—Diarrhoea—Estropipate—osteoporosis	0.000209	0.000561	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Risedronate—osteoporosis	0.000208	0.00056	CcSEcCtD
Imiquimod—Infection—Zoledronate—osteoporosis	0.000208	0.000559	CcSEcCtD
Imiquimod—Fatigue—Risedronate—osteoporosis	0.000208	0.000559	CcSEcCtD
Imiquimod—Insomnia—Pamidronate—osteoporosis	0.000207	0.000557	CcSEcCtD
Imiquimod—Pruritus—Ibandronate—osteoporosis	0.000207	0.000556	CcSEcCtD
Imiquimod—Pain—Risedronate—osteoporosis	0.000206	0.000554	CcSEcCtD
Imiquimod—Angiopathy—Estradiol—osteoporosis	0.000206	0.000554	CcSEcCtD
Imiquimod—Shock—Zoledronate—osteoporosis	0.000206	0.000554	CcSEcCtD
Imiquimod—Paraesthesia—Pamidronate—osteoporosis	0.000206	0.000553	CcSEcCtD
Imiquimod—Diarrhoea—Alendronate—osteoporosis	0.000205	0.000553	CcSEcCtD
Imiquimod—Asthenia—Calcitriol—osteoporosis	0.000205	0.000552	CcSEcCtD
Imiquimod—Nervous system disorder—Zoledronate—osteoporosis	0.000205	0.000552	CcSEcCtD
Imiquimod—Immune system disorder—Estradiol—osteoporosis	0.000205	0.000551	CcSEcCtD
Imiquimod—Mediastinal disorder—Estradiol—osteoporosis	0.000205	0.00055	CcSEcCtD
Imiquimod—Dyspnoea—Pamidronate—osteoporosis	0.000204	0.000549	CcSEcCtD
Imiquimod—Tachycardia—Zoledronate—osteoporosis	0.000204	0.000549	CcSEcCtD
Imiquimod—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000204	0.000548	CcSEcCtD
Imiquimod—Chills—Estradiol—osteoporosis	0.000204	0.000548	CcSEcCtD
Imiquimod—Somnolence—Pamidronate—osteoporosis	0.000204	0.000548	CcSEcCtD
Imiquimod—Skin disorder—Zoledronate—osteoporosis	0.000203	0.000547	CcSEcCtD
Imiquimod—Pruritus—Calcitriol—osteoporosis	0.000202	0.000545	CcSEcCtD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—osteoporosis	0.000202	0.00174	CbGpPWpGaD
Imiquimod—Hyperhidrosis—Zoledronate—osteoporosis	0.000202	0.000544	CcSEcCtD
Imiquimod—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000202	0.000544	CcSEcCtD
Imiquimod—Diarrhoea—Raloxifene—osteoporosis	0.000202	0.000544	CcSEcCtD
Imiquimod—Dyspepsia—Pamidronate—osteoporosis	0.000202	0.000542	CcSEcCtD
Imiquimod—Dizziness—Estropipate—osteoporosis	0.000202	0.000542	CcSEcCtD
Imiquimod—Oedema—Conjugated Estrogens—osteoporosis	0.000201	0.000542	CcSEcCtD
Imiquimod—CYP1A2—Biological oxidations—CYP27A1—osteoporosis	0.000201	0.00173	CbGpPWpGaD
Imiquimod—Alopecia—Estradiol—osteoporosis	0.000201	0.000539	CcSEcCtD
Imiquimod—Infection—Conjugated Estrogens—osteoporosis	0.0002	0.000538	CcSEcCtD
Imiquimod—Diarrhoea—Ibandronate—osteoporosis	0.0002	0.000538	CcSEcCtD
Imiquimod—Anorexia—Zoledronate—osteoporosis	0.000199	0.000536	CcSEcCtD
Imiquimod—Decreased appetite—Pamidronate—osteoporosis	0.000199	0.000536	CcSEcCtD
Imiquimod—Mental disorder—Estradiol—osteoporosis	0.000199	0.000535	CcSEcCtD
Imiquimod—Dizziness—Alendronate—osteoporosis	0.000199	0.000534	CcSEcCtD
Imiquimod—CYP1A2—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000199	0.00171	CbGpPWpGaD
Imiquimod—Shock—Conjugated Estrogens—osteoporosis	0.000198	0.000533	CcSEcCtD
Imiquimod—CYP1A2—Metapathway biotransformation—CYP27A1—osteoporosis	0.000198	0.00171	CbGpPWpGaD
Imiquimod—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000198	0.000532	CcSEcCtD
Imiquimod—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000198	0.000531	CcSEcCtD
Imiquimod—Erythema—Estradiol—osteoporosis	0.000198	0.000531	CcSEcCtD
Imiquimod—Malnutrition—Estradiol—osteoporosis	0.000198	0.000531	CcSEcCtD
Imiquimod—Fatigue—Pamidronate—osteoporosis	0.000197	0.000531	CcSEcCtD
Imiquimod—Gastrointestinal pain—Risedronate—osteoporosis	0.000197	0.00053	CcSEcCtD
Imiquimod—Tachycardia—Conjugated Estrogens—osteoporosis	0.000197	0.000529	CcSEcCtD
Imiquimod—Urticaria—Ethinyl Estradiol—osteoporosis	0.000196	0.000528	CcSEcCtD
Imiquimod—Pain—Pamidronate—osteoporosis	0.000196	0.000527	CcSEcCtD
Imiquimod—Diarrhoea—Calcitriol—osteoporosis	0.000196	0.000527	CcSEcCtD
Imiquimod—Skin disorder—Conjugated Estrogens—osteoporosis	0.000196	0.000526	CcSEcCtD
Imiquimod—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000195	0.000525	CcSEcCtD
Imiquimod—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000195	0.000525	CcSEcCtD
Imiquimod—Dizziness—Raloxifene—osteoporosis	0.000195	0.000525	CcSEcCtD
Imiquimod—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000195	0.000524	CcSEcCtD
Imiquimod—Vomiting—Estropipate—osteoporosis	0.000194	0.000521	CcSEcCtD
Imiquimod—Dizziness—Ibandronate—osteoporosis	0.000193	0.00052	CcSEcCtD
Imiquimod—Rash—Estropipate—osteoporosis	0.000192	0.000517	CcSEcCtD
Imiquimod—Dermatitis—Estropipate—osteoporosis	0.000192	0.000517	CcSEcCtD
Imiquimod—Anorexia—Conjugated Estrogens—osteoporosis	0.000192	0.000517	CcSEcCtD
Imiquimod—Urticaria—Risedronate—osteoporosis	0.000191	0.000515	CcSEcCtD
Imiquimod—Back pain—Estradiol—osteoporosis	0.000191	0.000514	CcSEcCtD
Imiquimod—Headache—Estropipate—osteoporosis	0.000191	0.000514	CcSEcCtD
Imiquimod—Vomiting—Alendronate—osteoporosis	0.000191	0.000514	CcSEcCtD
Imiquimod—TLR8—Immune System—IRS1—osteoporosis	0.000191	0.00164	CbGpPWpGaD
Imiquimod—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000191	0.000513	CcSEcCtD
Imiquimod—Body temperature increased—Risedronate—osteoporosis	0.00019	0.000512	CcSEcCtD
Imiquimod—Abdominal pain—Risedronate—osteoporosis	0.00019	0.000512	CcSEcCtD
Imiquimod—TLR7—Immune System—AGER—osteoporosis	0.00019	0.00164	CbGpPWpGaD
Imiquimod—Rash—Alendronate—osteoporosis	0.000189	0.000509	CcSEcCtD
Imiquimod—Insomnia—Zoledronate—osteoporosis	0.000189	0.000509	CcSEcCtD
Imiquimod—TLR7—Immune System—ADCY5—osteoporosis	0.000189	0.00163	CbGpPWpGaD
Imiquimod—Dermatitis—Alendronate—osteoporosis	0.000189	0.000509	CcSEcCtD
Imiquimod—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.000189	0.00163	CbGpPWpGaD
Imiquimod—Feeling abnormal—Pamidronate—osteoporosis	0.000189	0.000508	CcSEcCtD
Imiquimod—Headache—Alendronate—osteoporosis	0.000188	0.000506	CcSEcCtD
Imiquimod—Paraesthesia—Zoledronate—osteoporosis	0.000188	0.000505	CcSEcCtD
Imiquimod—Vomiting—Raloxifene—osteoporosis	0.000188	0.000505	CcSEcCtD
Imiquimod—Gastrointestinal pain—Pamidronate—osteoporosis	0.000187	0.000504	CcSEcCtD
Imiquimod—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.000187	0.00161	CbGpPWpGaD
Imiquimod—Dyspnoea—Zoledronate—osteoporosis	0.000187	0.000502	CcSEcCtD
Imiquimod—Rash—Raloxifene—osteoporosis	0.000186	0.000501	CcSEcCtD
Imiquimod—Dermatitis—Raloxifene—osteoporosis	0.000186	0.0005	CcSEcCtD
Imiquimod—Somnolence—Zoledronate—osteoporosis	0.000186	0.0005	CcSEcCtD
Imiquimod—Vomiting—Ibandronate—osteoporosis	0.000186	0.0005	CcSEcCtD
Imiquimod—Headache—Raloxifene—osteoporosis	0.000185	0.000498	CcSEcCtD
Imiquimod—Rash—Ibandronate—osteoporosis	0.000184	0.000496	CcSEcCtD
Imiquimod—Dermatitis—Ibandronate—osteoporosis	0.000184	0.000495	CcSEcCtD
Imiquimod—Dyspepsia—Zoledronate—osteoporosis	0.000184	0.000495	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000184	0.000494	CcSEcCtD
Imiquimod—Ill-defined disorder—Estradiol—osteoporosis	0.000183	0.000493	CcSEcCtD
Imiquimod—Headache—Ibandronate—osteoporosis	0.000183	0.000493	CcSEcCtD
Imiquimod—Insomnia—Conjugated Estrogens—osteoporosis	0.000182	0.00049	CcSEcCtD
Imiquimod—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000182	0.00049	CcSEcCtD
Imiquimod—Vomiting—Calcitriol—osteoporosis	0.000182	0.000489	CcSEcCtD
Imiquimod—Decreased appetite—Zoledronate—osteoporosis	0.000182	0.000489	CcSEcCtD
Imiquimod—Agitation—Estradiol—osteoporosis	0.000182	0.000488	CcSEcCtD
Imiquimod—Nausea—Estropipate—osteoporosis	0.000181	0.000487	CcSEcCtD
Imiquimod—Abdominal pain—Pamidronate—osteoporosis	0.000181	0.000487	CcSEcCtD
Imiquimod—Body temperature increased—Pamidronate—osteoporosis	0.000181	0.000487	CcSEcCtD
Imiquimod—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000181	0.000487	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000181	0.000486	CcSEcCtD
Imiquimod—Angioedema—Estradiol—osteoporosis	0.000181	0.000486	CcSEcCtD
Imiquimod—Rash—Calcitriol—osteoporosis	0.00018	0.000485	CcSEcCtD
Imiquimod—Fatigue—Zoledronate—osteoporosis	0.00018	0.000485	CcSEcCtD
Imiquimod—Dermatitis—Calcitriol—osteoporosis	0.00018	0.000485	CcSEcCtD
Imiquimod—Dyspnoea—Conjugated Estrogens—osteoporosis	0.00018	0.000483	CcSEcCtD
Imiquimod—Headache—Calcitriol—osteoporosis	0.000179	0.000482	CcSEcCtD
Imiquimod—TLR8—Immune System—IL6R—osteoporosis	0.000179	0.00154	CbGpPWpGaD
Imiquimod—Somnolence—Conjugated Estrogens—osteoporosis	0.000179	0.000482	CcSEcCtD
Imiquimod—Pain—Zoledronate—osteoporosis	0.000179	0.000481	CcSEcCtD
Imiquimod—Nausea—Alendronate—osteoporosis	0.000178	0.00048	CcSEcCtD
Imiquimod—Malaise—Estradiol—osteoporosis	0.000178	0.000479	CcSEcCtD
Imiquimod—Hypersensitivity—Risedronate—osteoporosis	0.000178	0.000477	CcSEcCtD
Imiquimod—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000177	0.000477	CcSEcCtD
Imiquimod—Asthenia—Ethinyl Estradiol—osteoporosis	0.000177	0.000477	CcSEcCtD
Imiquimod—Syncope—Estradiol—osteoporosis	0.000177	0.000477	CcSEcCtD
Imiquimod—Nausea—Raloxifene—osteoporosis	0.000175	0.000472	CcSEcCtD
Imiquimod—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000175	0.000471	CcSEcCtD
Imiquimod—Pruritus—Ethinyl Estradiol—osteoporosis	0.000175	0.00047	CcSEcCtD
Imiquimod—Palpitations—Estradiol—osteoporosis	0.000175	0.00047	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000174	0.000468	CcSEcCtD
Imiquimod—Fatigue—Conjugated Estrogens—osteoporosis	0.000174	0.000467	CcSEcCtD
Imiquimod—Nausea—Ibandronate—osteoporosis	0.000174	0.000467	CcSEcCtD
Imiquimod—Loss of consciousness—Estradiol—osteoporosis	0.000174	0.000467	CcSEcCtD
Imiquimod—Asthenia—Risedronate—osteoporosis	0.000173	0.000465	CcSEcCtD
Imiquimod—Feeling abnormal—Zoledronate—osteoporosis	0.000172	0.000464	CcSEcCtD
Imiquimod—Cough—Estradiol—osteoporosis	0.000172	0.000464	CcSEcCtD
Imiquimod—Pain—Conjugated Estrogens—osteoporosis	0.000172	0.000463	CcSEcCtD
Imiquimod—Gastrointestinal pain—Zoledronate—osteoporosis	0.000171	0.00046	CcSEcCtD
Imiquimod—Hypertension—Estradiol—osteoporosis	0.000171	0.000459	CcSEcCtD
Imiquimod—Pruritus—Risedronate—osteoporosis	0.00017	0.000459	CcSEcCtD
Imiquimod—Nausea—Calcitriol—osteoporosis	0.00017	0.000457	CcSEcCtD
Imiquimod—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000169	0.000455	CcSEcCtD
Imiquimod—Hypersensitivity—Pamidronate—osteoporosis	0.000169	0.000454	CcSEcCtD
Imiquimod—Myalgia—Estradiol—osteoporosis	0.000168	0.000452	CcSEcCtD
Imiquimod—Arthralgia—Estradiol—osteoporosis	0.000168	0.000452	CcSEcCtD
Imiquimod—Chest pain—Estradiol—osteoporosis	0.000168	0.000452	CcSEcCtD
Imiquimod—Anxiety—Estradiol—osteoporosis	0.000168	0.000451	CcSEcCtD
Imiquimod—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000167	0.000449	CcSEcCtD
Imiquimod—Urticaria—Zoledronate—osteoporosis	0.000166	0.000447	CcSEcCtD
Imiquimod—Discomfort—Estradiol—osteoporosis	0.000166	0.000447	CcSEcCtD
Imiquimod—TLR7—Immune System—IRS2—osteoporosis	0.000166	0.00143	CbGpPWpGaD
Imiquimod—Body temperature increased—Zoledronate—osteoporosis	0.000165	0.000445	CcSEcCtD
Imiquimod—Abdominal pain—Zoledronate—osteoporosis	0.000165	0.000445	CcSEcCtD
Imiquimod—Diarrhoea—Risedronate—osteoporosis	0.000165	0.000443	CcSEcCtD
Imiquimod—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000165	0.000443	CcSEcCtD
Imiquimod—Dry mouth—Estradiol—osteoporosis	0.000164	0.000442	CcSEcCtD
Imiquimod—Asthenia—Pamidronate—osteoporosis	0.000164	0.000442	CcSEcCtD
Imiquimod—Dizziness—Ethinyl Estradiol—osteoporosis	0.000163	0.00044	CcSEcCtD
Imiquimod—Pruritus—Pamidronate—osteoporosis	0.000162	0.000436	CcSEcCtD
Imiquimod—Oedema—Estradiol—osteoporosis	0.000161	0.000434	CcSEcCtD
Imiquimod—Infection—Estradiol—osteoporosis	0.00016	0.000431	CcSEcCtD
Imiquimod—Urticaria—Conjugated Estrogens—osteoporosis	0.00016	0.00043	CcSEcCtD
Imiquimod—Dizziness—Risedronate—osteoporosis	0.000159	0.000429	CcSEcCtD
Imiquimod—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000159	0.000428	CcSEcCtD
Imiquimod—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000159	0.000428	CcSEcCtD
Imiquimod—Shock—Estradiol—osteoporosis	0.000159	0.000427	CcSEcCtD
Imiquimod—Nervous system disorder—Estradiol—osteoporosis	0.000158	0.000425	CcSEcCtD
Imiquimod—Tachycardia—Estradiol—osteoporosis	0.000157	0.000423	CcSEcCtD
Imiquimod—Vomiting—Ethinyl Estradiol—osteoporosis	0.000157	0.000423	CcSEcCtD
Imiquimod—Diarrhoea—Pamidronate—osteoporosis	0.000157	0.000422	CcSEcCtD
Imiquimod—Skin disorder—Estradiol—osteoporosis	0.000157	0.000421	CcSEcCtD
Imiquimod—Hyperhidrosis—Estradiol—osteoporosis	0.000156	0.000419	CcSEcCtD
Imiquimod—Rash—Ethinyl Estradiol—osteoporosis	0.000156	0.000419	CcSEcCtD
Imiquimod—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000156	0.000419	CcSEcCtD
Imiquimod—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	0.000155	0.00134	CbGpPWpGaD
Imiquimod—Headache—Ethinyl Estradiol—osteoporosis	0.000155	0.000416	CcSEcCtD
Imiquimod—Hypersensitivity—Zoledronate—osteoporosis	0.000154	0.000415	CcSEcCtD
Imiquimod—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000153	0.00132	CbGpPWpGaD
Imiquimod—Vomiting—Risedronate—osteoporosis	0.000153	0.000412	CcSEcCtD
Imiquimod—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	0.000153	0.00132	CbGpPWpGaD
Imiquimod—Rash—Risedronate—osteoporosis	0.000152	0.000409	CcSEcCtD
Imiquimod—Dermatitis—Risedronate—osteoporosis	0.000152	0.000408	CcSEcCtD
Imiquimod—Dizziness—Pamidronate—osteoporosis	0.000151	0.000407	CcSEcCtD
Imiquimod—Headache—Risedronate—osteoporosis	0.000151	0.000406	CcSEcCtD
Imiquimod—Asthenia—Zoledronate—osteoporosis	0.00015	0.000404	CcSEcCtD
Imiquimod—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000148	0.000399	CcSEcCtD
Imiquimod—Pruritus—Zoledronate—osteoporosis	0.000148	0.000398	CcSEcCtD
Imiquimod—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.000147	0.00127	CbGpPWpGaD
Imiquimod—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000147	0.000395	CcSEcCtD
Imiquimod—Nausea—Ethinyl Estradiol—osteoporosis	0.000147	0.000395	CcSEcCtD
Imiquimod—Insomnia—Estradiol—osteoporosis	0.000146	0.000392	CcSEcCtD
Imiquimod—Vomiting—Pamidronate—osteoporosis	0.000146	0.000392	CcSEcCtD
Imiquimod—Paraesthesia—Estradiol—osteoporosis	0.000145	0.000389	CcSEcCtD
Imiquimod—Asthenia—Conjugated Estrogens—osteoporosis	0.000145	0.000389	CcSEcCtD
Imiquimod—TLR7—Immune System—IRS1—osteoporosis	0.000145	0.00125	CbGpPWpGaD
Imiquimod—Rash—Pamidronate—osteoporosis	0.000144	0.000388	CcSEcCtD
Imiquimod—Dermatitis—Pamidronate—osteoporosis	0.000144	0.000388	CcSEcCtD
Imiquimod—Dyspnoea—Estradiol—osteoporosis	0.000144	0.000387	CcSEcCtD
Imiquimod—Headache—Pamidronate—osteoporosis	0.000143	0.000386	CcSEcCtD
Imiquimod—Somnolence—Estradiol—osteoporosis	0.000143	0.000386	CcSEcCtD
Imiquimod—Diarrhoea—Zoledronate—osteoporosis	0.000143	0.000385	CcSEcCtD
Imiquimod—Nausea—Risedronate—osteoporosis	0.000143	0.000385	CcSEcCtD
Imiquimod—Pruritus—Conjugated Estrogens—osteoporosis	0.000143	0.000383	CcSEcCtD
Imiquimod—Dyspepsia—Estradiol—osteoporosis	0.000142	0.000382	CcSEcCtD
Imiquimod—Decreased appetite—Estradiol—osteoporosis	0.00014	0.000377	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Estradiol—osteoporosis	0.000139	0.000374	CcSEcCtD
Imiquimod—Fatigue—Estradiol—osteoporosis	0.000139	0.000374	CcSEcCtD
Imiquimod—Dizziness—Zoledronate—osteoporosis	0.000138	0.000372	CcSEcCtD
Imiquimod—Pain—Estradiol—osteoporosis	0.000138	0.000371	CcSEcCtD
Imiquimod—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000138	0.000371	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—IL6—osteoporosis	0.000137	0.00118	CbGpPWpGaD
Imiquimod—TLR8—Immune System—IL1B—osteoporosis	0.000136	0.00117	CbGpPWpGaD
Imiquimod—Nausea—Pamidronate—osteoporosis	0.000136	0.000366	CcSEcCtD
Imiquimod—TLR7—Immune System—IL6R—osteoporosis	0.000136	0.00117	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—osteoporosis	0.000135	0.00116	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.000134	0.00116	CbGpPWpGaD
Imiquimod—Dizziness—Conjugated Estrogens—osteoporosis	0.000133	0.000358	CcSEcCtD
Imiquimod—Vomiting—Zoledronate—osteoporosis	0.000133	0.000358	CcSEcCtD
Imiquimod—Feeling abnormal—Estradiol—osteoporosis	0.000133	0.000357	CcSEcCtD
Imiquimod—Rash—Zoledronate—osteoporosis	0.000132	0.000355	CcSEcCtD
Imiquimod—Gastrointestinal pain—Estradiol—osteoporosis	0.000132	0.000355	CcSEcCtD
Imiquimod—Dermatitis—Zoledronate—osteoporosis	0.000132	0.000355	CcSEcCtD
Imiquimod—Headache—Zoledronate—osteoporosis	0.000131	0.000353	CcSEcCtD
Imiquimod—Vomiting—Conjugated Estrogens—osteoporosis	0.000128	0.000345	CcSEcCtD
Imiquimod—Urticaria—Estradiol—osteoporosis	0.000128	0.000345	CcSEcCtD
Imiquimod—Body temperature increased—Estradiol—osteoporosis	0.000127	0.000343	CcSEcCtD
Imiquimod—Abdominal pain—Estradiol—osteoporosis	0.000127	0.000343	CcSEcCtD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.000127	0.0011	CbGpPWpGaD
Imiquimod—Rash—Conjugated Estrogens—osteoporosis	0.000127	0.000342	CcSEcCtD
Imiquimod—Dermatitis—Conjugated Estrogens—osteoporosis	0.000127	0.000341	CcSEcCtD
Imiquimod—Headache—Conjugated Estrogens—osteoporosis	0.000126	0.000339	CcSEcCtD
Imiquimod—Nausea—Zoledronate—osteoporosis	0.000124	0.000334	CcSEcCtD
Imiquimod—Nausea—Conjugated Estrogens—osteoporosis	0.00012	0.000322	CcSEcCtD
Imiquimod—CYP1A2—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.000119	0.00103	CbGpPWpGaD
Imiquimod—Hypersensitivity—Estradiol—osteoporosis	0.000119	0.00032	CcSEcCtD
Imiquimod—Asthenia—Estradiol—osteoporosis	0.000116	0.000311	CcSEcCtD
Imiquimod—Pruritus—Estradiol—osteoporosis	0.000114	0.000307	CcSEcCtD
Imiquimod—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.000114	0.000979	CbGpPWpGaD
Imiquimod—Diarrhoea—Estradiol—osteoporosis	0.00011	0.000297	CcSEcCtD
Imiquimod—Dizziness—Estradiol—osteoporosis	0.000107	0.000287	CcSEcCtD
Imiquimod—CYP1A2—Biological oxidations—CYP19A1—osteoporosis	0.000105	0.000909	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—MYC—osteoporosis	0.000105	0.000907	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—osteoporosis	0.000105	0.000905	CbGpPWpGaD
Imiquimod—CYP1A2—Metapathway biotransformation—CYP19A1—osteoporosis	0.000104	0.000897	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—IL6—osteoporosis	0.000104	0.000895	CbGpPWpGaD
Imiquimod—TLR7—Immune System—IL1B—osteoporosis	0.000103	0.00089	CbGpPWpGaD
Imiquimod—Vomiting—Estradiol—osteoporosis	0.000103	0.000276	CcSEcCtD
Imiquimod—Rash—Estradiol—osteoporosis	0.000102	0.000273	CcSEcCtD
Imiquimod—Dermatitis—Estradiol—osteoporosis	0.000102	0.000273	CcSEcCtD
Imiquimod—Headache—Estradiol—osteoporosis	0.000101	0.000272	CcSEcCtD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	9.9e-05	0.000853	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—TNF—osteoporosis	9.8e-05	0.000845	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—osteoporosis	9.8e-05	0.000845	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	9.64e-05	0.000831	CbGpPWpGaD
Imiquimod—Nausea—Estradiol—osteoporosis	9.58e-05	0.000258	CcSEcCtD
Imiquimod—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	9.21e-05	0.000794	CbGpPWpGaD
Imiquimod—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	8.14e-05	0.000702	CbGpPWpGaD
Imiquimod—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	8.03e-05	0.000692	CbGpPWpGaD
Imiquimod—TLR8—Immune System—IL6—osteoporosis	7.98e-05	0.000688	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	7.71e-05	0.000665	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	6.56e-05	0.000565	CbGpPWpGaD
Imiquimod—CYP1A2—Biological oxidations—POMC—osteoporosis	6.34e-05	0.000546	CbGpPWpGaD
Imiquimod—TLR7—Immune System—IL6—osteoporosis	6.05e-05	0.000521	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PKM—osteoporosis	5.98e-05	0.000515	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—FDPS—osteoporosis	5.98e-05	0.000515	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—GPD2—osteoporosis	5.67e-05	0.000489	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PGLS—osteoporosis	5.67e-05	0.000489	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ATIC—osteoporosis	5.18e-05	0.000447	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PNP—osteoporosis	5.18e-05	0.000447	CbGpPWpGaD
Imiquimod—CYP3A4—Biological oxidations—POMC—osteoporosis	4.89e-05	0.000422	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—FDPS—osteoporosis	4.61e-05	0.000398	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PKM—osteoporosis	4.61e-05	0.000398	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—OXCT1—osteoporosis	4.41e-05	0.00038	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CA2—osteoporosis	4.41e-05	0.00038	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PGLS—osteoporosis	4.37e-05	0.000377	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—GPD2—osteoporosis	4.37e-05	0.000377	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—MGLL—osteoporosis	4.3e-05	0.00037	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	4.05e-05	0.000349	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ATIC—osteoporosis	4e-05	0.000345	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PNP—osteoporosis	4e-05	0.000345	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—IDH2—osteoporosis	3.65e-05	0.000315	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CYP27A1—osteoporosis	3.43e-05	0.000296	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—OXCT1—osteoporosis	3.4e-05	0.000293	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CA2—osteoporosis	3.4e-05	0.000293	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ACP5—osteoporosis	3.34e-05	0.000288	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—MGLL—osteoporosis	3.31e-05	0.000286	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	3.3e-05	0.000284	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—TPI1—osteoporosis	3.11e-05	0.000268	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—P4HB—osteoporosis	2.92e-05	0.000252	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—GAPDH—osteoporosis	2.87e-05	0.000247	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—IDH2—osteoporosis	2.82e-05	0.000243	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—RAP1A—osteoporosis	2.79e-05	0.000241	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CYP27A1—osteoporosis	2.65e-05	0.000228	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ACP5—osteoporosis	2.58e-05	0.000222	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2.43e-05	0.00021	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—TPI1—osteoporosis	2.4e-05	0.000207	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ENO1—osteoporosis	2.26e-05	0.000195	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—P4HB—osteoporosis	2.25e-05	0.000194	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PSMA5—osteoporosis	2.22e-05	0.000192	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PSMA2—osteoporosis	2.22e-05	0.000192	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—GAPDH—osteoporosis	2.21e-05	0.000191	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—RAP1A—osteoporosis	2.15e-05	0.000186	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CYP19A1—osteoporosis	1.8e-05	0.000156	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ENO1—osteoporosis	1.74e-05	0.00015	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PSMA2—osteoporosis	1.72e-05	0.000148	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PSMA5—osteoporosis	1.72e-05	0.000148	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ADCY5—osteoporosis	1.47e-05	0.000127	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—GPX1—osteoporosis	1.47e-05	0.000127	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CYP19A1—osteoporosis	1.39e-05	0.00012	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—MTHFR—osteoporosis	1.36e-05	0.000117	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ADCY5—osteoporosis	1.14e-05	9.81e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—GPX1—osteoporosis	1.13e-05	9.77e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—POMC—osteoporosis	1.08e-05	9.35e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—MTHFR—osteoporosis	1.05e-05	9.02e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—POMC—osteoporosis	8.37e-06	7.21e-05	CbGpPWpGaD
